# Evaluation of Sildenafil for the Treatment of Moderate Congestive Heart Failure

> **NCT00793338** · PHASE4 · WITHDRAWN · sponsor: **University of New Mexico**

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Sildenafil

## Key facts

- **NCT ID:** NCT00793338
- **Lead sponsor:** University of New Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-11
- **Primary completion:** 2010-11
- **Final completion:** 2011-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The project was not funded and could not be initiated.
- **Last updated:** 2023-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00793338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00793338, "Evaluation of Sildenafil for the Treatment of Moderate Congestive Heart Failure". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00793338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*